Sign Up to like & get
recommendations!
1
Published in 2022 at "Oxidative Medicine and Cellular Longevity"
DOI: 10.1155/2022/2679154
Abstract: Background T lymphoblastic lymphoma/leukemia (T-LBL/ALL) is an aggressive malignant tumor with 5-year overall survival (OS) rate reached 80% after high-dose chemotherapy. Due to the relatively low incidence of T-LBL/ALL, only a few risk factors have…
read more here.
Keywords:
stress;
lymphoblastic lymphoma;
lbl patients;
stress indexes ... See more keywords